Tissue microarrays enabling high-throughput molecular pathology.
The tissue microarray has enabled high-throughput pathology. Rather than the laborious review of individual slides and issues of assay reproducibility across large series of specimens, tissue microarrays allow the review of a single stain on a single slide containing tens to hundreds of samples. This is a paradigm shift in pathology, away from histomorphology and toward molecular characterization by immunohistochemistry. This platform allows large retrospective clinical studies of biomarkers for correlation with outcome and can equally well be applied toward high-throughput analysis of cell lines and xenografts. Tissue microarrays encourage novel approaches to assaying tissue with retained histomorphology and have enabled image analysis in pathology. The reduction of tissue to an analyte for high-throughput analysis has highlighted the importance of a high quality tissue and the impact of tissue handling and processing in the quality of data that can be obtained from analysis of tissue.
Takikita
Mikiko
M
Tissue Array Research Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, TARP Lab, MSC 4605, Bethesda, MD 20892-4605, USA.
Chung
Joon-Yong
JY
Hewitt
Stephen M
SM
D006801:Humans; D010338:Pathology, Clinical / Q000379:methods*; D040901:Proteomics / Q000379:methods; D015203:Reproducibility of Results; D046888:Tissue Array Analysis / Q000379:methods*